Ethical issues in field trials of genetically modified disease-resistant mosquitoes

Developing World Bioethics

Volumn 14, Issue 1, 2014, Pages 37-46

  Resnik, David B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Environmental impacts; Ethics; Field trials; Genetically modified mosquitoes; Informed consent; Malaria; Public health

Indexed keywords

ANIMAL; DISEASE CARRIER; ETHICS; GENETIC ENGINEERING; GENETICS; HUMAN; INFORMED CONSENT; MALARIA; MOSQUITO; PARASITOLOGY; PLASMODIUM; PUBLIC HEALTH; TRANSMISSION;

ANIMALS; CULICIDAE; GENETIC ENGINEERING; HUMANS; INFORMED CONSENT; INSECT VECTORS; MALARIA; PLASMODIUM; PUBLIC HEALTH;

EID: 84897592913     PISSN: 14718731     EISSN: 14718847     Source Type: Journal    
DOI: 10.1111/dewb.12011     Document Type: Article

References (51)

1. Roll Back Malaria. 2012. Key Facts. Available at: http://www.rbm.who.int/keyfacts.html [Accessed 5 Nov 2012].
2. Centers for Disease Control and Prevention. Dengue. Available at: http://www.cdc.gov/Dengue/ [Accessed 5 Nov 2012].
3. Centers for Disease Control and Prevention. 2012. Mosquito-Borne Diseases. Available at: http://www.cdc.gov/ncidod/diseases/list_mosquitoborne.htm [Accessed 5 Nov 2012].
4. World Health Organization. 2010. WHO Global Malaria Programme. Available at: http://www.who.int/malaria/about_us/en/index.html [Accessed 5 Nov 2012].
5. A.F. Harris etal. Field Performance of Engineered Male Mosquitoes. Nat Biotechnol 2011; 29: 1034-1037.
6. M. Enserink. GM Mosquito Trial Alarms Opponents, Strains Ties in Gates-Funded Project. Science 2011; 330: 1030-1031.
7. A. Pollack. Concerns are Raised about Genetically Engineered Mosquitoes. New York Times, 30 October 2011; B1.
8. A. Maxmen. Florida Abuzz over Mosquito Plan. Nature 2012; 487: 286.
9. R.G. Reeves etal. Scientific Standards and the Regulation of Genetically Modified Insects. PLoS Negl Trop Dis 2012; 6: e1502.
10. Aultman K.S., et al., Research Ethics: Managing Risks of Arthropod Vector Research, Science, 2000, 288, 2321-2322.
11. D. Macer. 2003. Ethical, Legal and Social Issues of Genetically Modified Disease Vectors in Public Health. Geneva: World Health Organization.
12. World Health Organization. 2012. Guidance Framework for Testing of Genetically Modified Mosquitoes. Geneva: World Health Organization.
13. J.M. Marshall & C.E. Taylor. Transgenic Mosquitoes for Malaria Control. PLoS Medicine 2009; 6: e1000020.
14. D.S. Yamamoto, H. Nagumo & S. Yoshida. Flying Vaccinator A transgenic Mosquito Delivers a Leishmania Vaccine via Blood Feeding. Insect Mol Biol 2010; 19: 391-398.
15. Y. Dong etal. Engineered Anopheles Immunity to Plasmodium Infection. PLoS Pathogen 2011; 7: e1002458.
16. A.T. Isaacs etal. Transgenic Anopheles Stephensi Coexpressing Single-Chain Antibodies Resist Plasmodium Falciparum Development. Proc Natl Acad Sci USA 2012; 109: E1922-E1930.
17. S.P. Sinkins & F. Gould F. Gene Drive Systems for Insect Disease Vectors. Nature Review Genetics 2006; 7: 427-435.
18. J.V. Lavery, L.C. Harrington, & T.W. Scott. Ethical, Social, and Cultural Considerations for Site Selection for Research with Genetically Modified Mosquitoes. Am J Trop Med Hyg 2008; 79: 312-318.
19. S. James, C.P. Simmons, & A.A. James. Ecology. Mosquito trials. Science 2011; 334: 771-772.
20. J. Sim & A. Dawson. Informed Consent and Cluster-Randomized Trials. Am J Public Health 2012; 102: 480-485.
21. James, Simmons, & James, op. cit. note.
22. World Health Organization, op. cit., note.
23. Cartagena Protocol on Biosafety. 2012. About the Protocol. Available at: http://bch.cbd.int/protocol/background/ [Accessed 5 Nov 2012].
24. D.B. Resnik. 2012. Environmental Health Ethics. Cambridge: Cambridge University Press.
25. M. Benedict etal. Guidance for Contained Field Trials of Vector Mosquitoes Engineered to Contain a Gene Drive System: Recommendations of a Scientific Working Group. Vector Borne Zoonotic Dis 2008; 8: 127-166.
26. James, Simmons, & James, op. cit. note.
27. Marshall & Taylor, op. cit. note.
28. V.C. Barclay, etal. The Evolutionary Consequences of Blood-Stage Vaccination on the Rodent Malaria Plasmodium chabaudi. PLoS Biol 2012; 10: e1001368.
29. World Health Organization, op. cit., note.
30. Department of Health and Human Services. 2009. 45 CFR 46: Protection of Human Subjects.
31. Council for the Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects, 2002. Available at: http://www.cioms.ch/publications/layout_guide2002.pdf [Accessed 5 Nov 2012].
32. A.D. McRae etal. Who is the Research Subject in Cluster Randomized Trials in Health Research? Trials. 2011; 12: 183.
33. E.J. Emanuel, D. Wendler & C. Grady. What Makes Clinical Research Ethical? JAMA 2000; 283: 2701-2711.
34. E.J. Emanuel, etal. What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research. J Infect Dis 2004; 189: 930-937.
35. A.S. Shamoo & D.B. Resnik. 2009. Responsible Conduct of Research, 2nd ed. New York: Oxford Universtiy Press.
36. C. Elliott. Justice for Injured Research Subjects. N Engl J Med 2012; 367: 6-8.
37. Council for the Organizations of Medical Sciences, op. cit., note.
38. A. Wertheimer. 2010. Rethinking the Ethics of Clinical Research. New York: Oxford University Press.
39. Emanuel et al, op. cit., note.
40. Emanuel etal, op. cit., note.
41. C. Weijer & E.J. Emanuel. Ethics. Protecting Communities in Biomedical Research. Science 2000; 289: 1142-1144.
42. Lavery, Harrington, & Scott, op. cit., note.
43. J.V. Lavery etal. Towards a Framework for Community Engagement in Global Health Research. Trends Parasitol 2010; 26: 279-283.
44. Sim and Dawson, op. cit., note.
45. D.B. Resnik & R.R. Sharp. Protecting Third Parties in Human Subjects Research. IRB 2006; 28(4): 1-7.
46. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Department of Health, Education, and Welfare.
47. Council for the Organizations of Medical Sciences, op. cit., note.
48. Reference removed for blind review.
49. L.O. Gostin & K.G. Gostin. A Broader Liberty: J.S. Mill, Paternalism and the Public's Health. Public Health 2009; 123: 214-221.
50. N.E. Kass. An Ethics Framework for Public Health. Am J Public Health 2001; 91: 1776-1782.
51. Macer, op. cit. note.